Key result
Declining obesity trajectory linked to ~45% higher mortality and incident CVD versus stable or slow decline.
Why the study?
Research examining the role of obesity in CVD often fails to adequately consider heterogeneity in obesity severity, distribution, and duration.
Do different longitudinal trajectories of obesity severity and distribution affect the risk of mortality and incident cardiovascular disease in a biracial cohort?
Cohort (n=14,514)
Yes
Do different longitudinal trajectories of obesity severity and distribution affect the risk of mortality and incident cardiovascular disease in a biracial cohort?
Longitudinal trajectories of obesity, particularly declining or rapidly increasing BMI and waist circumference, are associated with differential risks of mortality and cardiovascular disease compared to stable trajectories.
Answers are grounded in this paper and cite their sources.
Declining obesity trajectories may warrant closer surveillance; leaves open whether interventions alter outcomes in observational data.
Background Research examining the role of obesity in cardiovascular disease (CVD) often fails to adequately consider heterogeneity in obesity severity, distribution, and duration. Methods and Results We here use multivariate latent class mixed models in the biracial Atherosclerosis Risk in Communities study (N=14 514; mean age=54 years; 55% female) to associate obesity subclasses (derived from body mass index, waist circumference, self‐reported weight at age 25, tricep skinfold, and calf circumference across up to four triennial visits) with total mortality, incident CVD, and CVD risk factors. We identified four obesity subclasses, summarized by their body mass index and waist circumference slope as decline (4.1%), stable/slow decline (67.8%), moderate increase (24.6%), and rapid increase (3.6%) subclasses. Compared with participants in the stable/slow decline subclass, the decline subclass was associated with elevated mortality (hazard ratio [HR] 1.45, 95% CI 1.31, 1.60, P <0.0001) and with heart failure (HR 1.41, 95% CI 1.22, 1.63, P <0.0001), stroke (HR 1.53, 95% CI 1.22, 1.92, P =0.0002), and coronary heart disease (HR 1.36, 95% CI 1.14, 1.63, P =0.0008), adjusting for baseline body mass index and CVD risk factor profile. The moderate increase latent class was not associated with any significant differences in CVD risk as compared to the stable/slow decline latent class and was associated with a lower overall risk of mortality (HR 0.85, 95% CI 0.80, 0.90, P <0.0001), despite higher body mass index at baseline. The rapid increase latent class was associated with a higher risk of heart failure versus the stable/slow decline latent class (HR 1.34, 95% CI 1.10, 1.62, P =0.004). Conclusions Consideration of heterogeneity and longitudinal changes in obesity measures is needed in clinical care for a more precision‐oriented view of CVD risk.
No takes yet. Share an insight, caveat, or question.
Raffield et al. (2021) conducted a cohort in Obesity and cardiovascular disease (n=14,514). Obesity subclasses (decline, moderate increase, rapid increase) vs. Stable/slow decline subclass was evaluated on Total mortality (HR 1.45, 95% CI 1.31, 1.60, p=<0.0001). A declining obesity trajectory was associated with elevated mortality and incident cardiovascular disease compared with a stable/slow decline trajectory.
Synapse has enriched 10 related papers. Consider them for comparative context: